MENU
+Compare
MLEC
Stock ticker: NASDAQ
AS OF
Aug 11, 01:38 PM (EDT)
Price
$2.74
Change
-$0.21 (-7.12%)
Capitalization
11.8M

MLEC Moolec Science SA Forecast, Technical & Fundamental Analysis

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape... Show more

MLEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MLEC with price predictions
Aug 08, 2025

MLEC's Indicator enters downward trend

The Aroon Indicator for MLEC entered a downward trend on August 08, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 143 similar instances where the Aroon Indicator formed such a pattern. In of the 143 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MLEC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 20 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Moving Average Convergence Divergence (MACD) for MLEC just turned positive on August 01, 2025. Looking at past instances where MLEC's MACD turned positive, the stock continued to rise in of 60 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MLEC advanced for three days, in of 112 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.219) is normal, around the industry mean (18.662). P/E Ratio (0.000) is within average values for comparable stocks, (54.033). MLEC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.909). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (1.445) is also within normal values, averaging (286.048).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MLEC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MLEC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
MLEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MLEC is expected to report earnings to rise 1,066.67% to -69 cents per share on October 27

Moolec Science SA MLEC Stock Earnings Reports
Q2'25
Est.
$-0.70
Q4'24
Est.
$-0.06
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.01
Q1'24
Beat
by $0.03
The last earnings report on March 12 showed earnings per share of -5 cents, meeting the estimate of -5 cents. With 4.49K shares outstanding, the current market capitalization sits at 11.80M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
17, Boulevard F.W. Raiffeisen
Phone
+352 26496565
Employees
12
Web
https://www.moolecscience.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STG9.650.23
+2.44%
Sunlands Technology Group
CAC37.320.66
+1.80%
Camden National Corp
MIRM59.970.15
+0.25%
Mirum Pharmaceuticals
HTCR0.49-0.01
-2.22%
Heartcore Enterprises
HUBS449.72-12.15
-2.63%
HUBSPOT

MLEC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MLEC has been loosely correlated with PVLA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if MLEC jumps, then PVLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLEC
1D Price
Change %
MLEC100%
N/A
PVLA - MLEC
54%
Loosely correlated
+4.74%
WINT - MLEC
53%
Loosely correlated
-6.78%
ABEO - MLEC
36%
Loosely correlated
-0.16%
NAGE - MLEC
25%
Poorly correlated
+1.25%
ENVB - MLEC
24%
Poorly correlated
N/A
More